Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited, commonly known as Sun Pharma, is a leading global pharmaceutical company headquartered in India. Founded in 1993, the company has established a strong presence in various operational regions, including North America, Europe, and Asia, focusing on the development and manufacturing of a wide range of pharmaceutical products. Specialising in generics, specialty pharmaceuticals, and over-the-counter medications, Sun Pharma is renowned for its commitment to quality and innovation. The company has achieved significant milestones, including becoming the largest pharmaceutical company in India and a prominent player in the global market. With a diverse portfolio that includes treatments for dermatology, oncology, and cardiology, Sun Pharma continues to enhance its market position through strategic acquisitions and a robust research and development pipeline.
DitchCarbon Score
How does Sun Pharma Laboratories Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sun Pharma Laboratories Limited's score of 52 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sun Pharma Laboratories Limited, headquartered in India, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sun Pharmaceutical Industries Limited, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Sun Pharma Laboratories Limited. The emissions data and performance metrics are cascaded from its parent company, Sun Pharmaceutical Industries Limited, at a cascade level of 1. This means that any climate initiatives or targets would be reflective of the broader corporate strategy of the parent organisation. In the absence of specific emissions figures, it is important to note that the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in initiatives such as the Carbon Disclosure Project (CDP) to enhance transparency and accountability in their environmental impact. Overall, while Sun Pharma Laboratories Limited does not currently report specific emissions data or reduction targets, its affiliation with Sun Pharmaceutical Industries Limited suggests a potential alignment with industry standards and practices aimed at addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 77,616,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 377,728,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sun Pharma Laboratories Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
